Related Experiment Video
Updated: May 23, 2026

08:06
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease
Tamara Shiner1, Ben Seymour, Klaus Wunderlich
1Wellcome Trust Centre for Neuroimaging, UCL, London, WC1N 3BG, UK. tamarashiner@gmail.com
Brain : a Journal of Neurology
|April 18, 2012
Summary
Dopamine replacement medication did not affect learning in Parkinson's disease patients. However, patients ON medication performed better, suggesting dopamine enhances generalization and choice behavior distinct from initial learning.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Pharmacology
Background:
- Dopamine's role in decision-making is crucial but not fully understood.
- Parkinson's disease offers a model to study dopamine's effects due to its dopamine deficiency.
Purpose of the Study:
- To investigate the precise role of dopamine in decision-making using Parkinson's disease patients.
- To differentiate dopamine's impact on learning versus performance in a reinforcement task.
Main Methods:
- Studied Parkinson's disease patients ON and OFF dopamine medication in a two-stage reinforcement learning task.
- Utilized functional magnetic resonance imaging (fMRI) to measure neural activity in nucleus accumbens and ventromedial prefrontal cortex.
Main Results:
- Dopamine medication state did not influence initial learning.
- Patients ON medication showed significantly better performance, indicating improved choice behavior and generalization.
- Neural activity in key brain regions during performance correlated with better outcomes, but only when ON medication.
Conclusions:
- Dopamine's primary role in this context is not in learning but in facilitating performance and generalization of learned information.
- Dopamine modulation of nucleus accumbens and ventromedial prefrontal cortex impacts choice behavior distinctly from learning.
- Findings support a dissociation between dopamine's role in learning and performance.
Related Concept Videos
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

